1.
|
Fomchenko EI and Holland EC: Stem cells
and brain cancer. Exp Cell Res. 306:323–329. 2005. View Article : Google Scholar : PubMed/NCBI
|
2.
|
Galderisi U, Cipollaro M and Giordano A:
Stem cells and brain cancer. Cell Death Differ. 13:5–11. 2006.
View Article : Google Scholar
|
3.
|
Kong BH, Park NR, Shim JK, et al:
Isolation of glioma cancer stem cells in relation to histological
grades in glioma specimens. Childs Nerv Syst. 29:217–229. 2013.
View Article : Google Scholar : PubMed/NCBI
|
4.
|
Liotta LA and Kohn EC: The
microenvironment of the tumour-host interface. Nature. 411:375–379.
2001. View
Article : Google Scholar : PubMed/NCBI
|
5.
|
Xouri G and Christian S: Origin and
function of tumor stroma fibroblasts. Semin Cell Dev Biol.
21:40–46. 2010. View Article : Google Scholar : PubMed/NCBI
|
6.
|
Shin GY, Shim JK, Lee JH, et al: Changes
in the biological characteristics of glioma cancer stem cells after
serial in vivo subtransplantation. Childs Nerv Syst. 29:55–64.
2013. View Article : Google Scholar : PubMed/NCBI
|
7.
|
Kong BH, Shin HD, Kim SH, et al: Increased
in vivo angiogenic effect of glioma stromal mesenchymal
stem-like cells on glioma cancer stem cells from patients with
glioblastoma. Int J Oncol. 42:1754–1762. 2013.
|
8.
|
Paget S: The distribution of secondary
growths in cancer of the breast. Lancet. 133:571–573. 1889.
View Article : Google Scholar
|
9.
|
Fidler IJ and Poste G: The ‘seed and soil’
hypothesis revisited. Lancet Oncol. 9:8082008.
|
10.
|
Mendoza M and Khanna C: Revisiting the
seed and soil in cancer metastasis. Int J Biochem Cell Biol.
41:1452–1462. 2009. View Article : Google Scholar : PubMed/NCBI
|
11.
|
Kim SM, Kang SG, Park NR, et al: Presence
of glioma stroma mesenchymal stem cells in a murine orthotopic
glioma model. Childs Nerv Syst. 27:911–922. 2011. View Article : Google Scholar : PubMed/NCBI
|
12.
|
Kim YG, Jeon S, Sin GY, et al: Existence
of glioma stroma mesenchymal stemlike cells in Korean glioma
specimens. Childs Nerv Syst. 29:549–563. 2013. View Article : Google Scholar : PubMed/NCBI
|
13.
|
Singh SK, Clarke ID, Terasaki M, et al:
Identification of a cancer stem cell in human brain tumors. Cancer
Res. 63:5821–5828. 2003.PubMed/NCBI
|
14.
|
Singh SK, Hawkins C, Clarke ID, et al:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
15.
|
Hoelzinger DB, Demuth T and Berens ME:
Autocrine factors that sustain glioma invasion and paracrine
biology in the brain microenvironment. J Natl Cancer Inst.
99:1583–1593. 2007. View Article : Google Scholar : PubMed/NCBI
|
16.
|
Oliver L, Olivier C, Marhuenda FB, Campone
M and Vallette FM: Hypoxia and the malignant glioma
microenvironment: regulation and implications for therapy. Curr Mol
Pharmacol. 2:263–284. 2009. View Article : Google Scholar : PubMed/NCBI
|
17.
|
Kanamori M, Kawaguchi T, Berger MS and
Pieper RO: Intracranial microenvironment reveals independent
opposing functions of host alphaVbeta3 expression on glioma growth
and angiogenesis. J Biol Chem. 281:37256–37264. 2006. View Article : Google Scholar
|
18.
|
Stewart PA, Farrell CL and Del Maestro RF:
The effect of cellular microenvironment on vessels in the brain.
Part 1: vessel structure in tumour, peritumour and brain from
humans with malignant glioma. Int J Radiat Biol. 60:125–130. 1991.
View Article : Google Scholar : PubMed/NCBI
|
19.
|
Kang SG, Shinojima N, Hossain A, et al:
Isolation and perivascular localization of mesenchymal stem cells
from mouse brain. Neurosurgery. 67:711–720. 2010. View Article : Google Scholar : PubMed/NCBI
|
20.
|
Lee CH, Jung KW, Yoo H, Park S and Lee SH:
Epidemiology of primary brain and central nervous system tumors in
Korea. J Korean Neurosurg Soc. 48:145–152. 2010. View Article : Google Scholar : PubMed/NCBI
|
21.
|
Hueng DY, Sytwu HK, Huang SM, Chang C and
Ma HI: Isolation and characterization of tumor stem-like cells from
human meningiomas. J Neurooncol. 104:45–53. 2011. View Article : Google Scholar : PubMed/NCBI
|
22.
|
Rath P, Miller DC, Litofsky NS, et al:
Isolation and characterization of a population of stem-like
progenitor cells from an atypical meningioma. Exp Mol Pathol.
90:179–188. 2011. View Article : Google Scholar : PubMed/NCBI
|
23.
|
Hu D, Wang X, Mao Y and Zhou L:
Identification of CD105 (endoglin)-positive stem-like cells in
rhabdoid meningioma. J Neurooncol. 106:505–517. 2012. View Article : Google Scholar : PubMed/NCBI
|
24.
|
Mosnier JF, Perret AG, Scoazec JY and
Brunon J: Expression of beta2 integrins and macrophage-associated
antigens in meningeal tumours. Virchows Arch. 436:131–137. 2000.
View Article : Google Scholar : PubMed/NCBI
|
25.
|
Kimura Y, Matsumae M and Tsutsumi Y:
Pericellular deposition of basement membrane material in myxoid
meningioma: immunohistochemical evidence for unbalanced production
of type IV collagen and laminin. Pathol Int. 48:53–57. 1998.
View Article : Google Scholar
|
26.
|
Shamah SM, Alberta JA, Giannobile WV, et
al: Detection of activated platelet-derived growth factor receptors
in human meningioma. Cancer Res. 57:4141–4147. 1997.PubMed/NCBI
|
27.
|
Nystrom SH: Fine structure of tumour
stroma and blood vessel stroma in human supratentorial menigioma.
Nature. 194:587–588. 1962. View Article : Google Scholar : PubMed/NCBI
|
28.
|
Majumdar K, Mandal S, Thakkar R, Saran RK
and Srivastava AK: Meningeal osteochondroma simulating meningioma
with metaplastic change: a rare golf-ball-like lesion of
non-meningothelial mesenchymal origin. Brain Tumor Pathol. Mar
2–2013.(Epub ahead of print).
|
29.
|
Celebre A, Wu MY, Danielson B, et al:
Anaplastic meningioma with extensive single-cell infiltration: a
potential role for epithelial-mesenchymal transformation in the
progression of a meningothelial tumour? Histopathology.
62:1111–1114. 2013. View Article : Google Scholar : PubMed/NCBI
|
30.
|
Louis DN, Ohgaki H, Wiestler OD, et al:
The 2007 WHO classification of tumours of the central nervous
system. Acta Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
31.
|
Mareschi K, Biasin E, Piacibello W,
Aglietta M, Madon E and Fagioli F: Isolation of human mesenchymal
stem cells: bone marrow versus umbilical cord blood. Haematologica.
86:1099–1100. 2001.PubMed/NCBI
|
32.
|
Lennon DP and Caplan AI: Isolation of
human marrow-derived mesenchymal stem cells. Exp Hematol.
34:1604–1605. 2006. View Article : Google Scholar : PubMed/NCBI
|
33.
|
Dominici M, Le Blanc K, Mueller I, et al:
Minimal criteria for defining multipotent mesenchymal stromal
cells. The International Society for Cellular Therapy position
statement. Cytotherapy. 8:315–317. 2006. View Article : Google Scholar
|
34.
|
Lal S, Lacroix M, Tofilon P, Fuller GN,
Sawaya R and Lang FF: An implantable guide-screw system for brain
tumor studies in small animals. J Neurosurg. 92:326–333. 2000.
View Article : Google Scholar : PubMed/NCBI
|
35.
|
Nakamizo A, Marini F, Amano T, et al:
Human bone marrow-derived mesenchymal stem cells in the treatment
of gliomas. Cancer Res. 65:3307–3318. 2005.PubMed/NCBI
|
36.
|
da Silva Meirelles L, Chagastelles PC and
Nardi NB: Mesenchymal stem cells reside in virtually all post-natal
organs and tissues. J Cell Sci. 119:2204–2213. 2006.PubMed/NCBI
|
37.
|
El-Haibi CP and Karnoub AE: Mesenchymal
stem cells in the pathogenesis and therapy of breast cancer. J
Mammary Gland Biol Neoplasia. 15:399–409. 2010. View Article : Google Scholar : PubMed/NCBI
|
38.
|
Karnoub AE, Dash AB, Vo AP, et al:
Mesenchymal stem cells within tumour stroma promote breast cancer
metastasis. Nature. 449:557–563. 2007. View Article : Google Scholar : PubMed/NCBI
|
39.
|
Hall B, Andreeff M and Marini F: The
participation of mesenchymal stem cells in tumor stroma formation
and their application as targeted-gene delivery vehicles. Handb Exp
Pharmacol. 180:263–283. 2007. View Article : Google Scholar : PubMed/NCBI
|
40.
|
Feigin I: Mixed mesenchymal tumors:
meningioma and nerve sheath tumor. J Neuropathol Exp Neurol.
37:459–470. 1978. View Article : Google Scholar : PubMed/NCBI
|
41.
|
Ng HK, Tse CC and Lo ST: Meningiomas and
arachnoid cells: an immunohistochemical study of epithelial
markers. Pathology. 19:253–257. 1987. View Article : Google Scholar : PubMed/NCBI
|
42.
|
Kamitani H, Masuzawa H, Kanazawa I and
Kubo T: Recurrence of convexity meningiomas: tumor cells in the
arachnoid membrane. Surg Neurol. 56:228–235. 2001. View Article : Google Scholar : PubMed/NCBI
|
43.
|
Lopes CA and Mair WG: Tubular structures
in arachnoid cells. Acta Neuropathol. 27:363–368. 1974. View Article : Google Scholar : PubMed/NCBI
|
44.
|
Ohnishi Y, Iwatsuki K, Morii E, et al:
Histopathological study of spinal meningioma originating from the
arachnoid villi. Brain Tumor Pathol. 28:77–81. 2011. View Article : Google Scholar : PubMed/NCBI
|
45.
|
Cheifetz S, Bellon T, Cales C, et al:
Endoglin is a component of the transforming growth factor-beta
receptor system in human endothelial cells. J Biol Chem.
267:19027–19030. 1992.PubMed/NCBI
|
46.
|
Behrem S, Zarkovic K, Eskinja N and Jonjic
N: Endoglin is a better marker than CD31 in evaluation of
angiogenesis in glioblastoma. Croat Med J. 46:417–422.
2005.PubMed/NCBI
|
47.
|
Barresi V and Barresi G: Endoglin: a
marker of neoplasias or rather of neo-angiogenesis? Head Neck.
32:970–971. 2010.PubMed/NCBI
|
48.
|
Yen BL, Huang HI, Chien CC, et al:
Isolation of multipotent cells from human term placenta. Stem
Cells. 23:3–9. 2005. View Article : Google Scholar : PubMed/NCBI
|
49.
|
Crisan M, Chen CW, Corselli M, Andriolo G,
Lazzari L and Peault B: Perivascular multipotent progenitor cells
in human organs. Ann NY Acad Sci. 1176:118–123. 2009. View Article : Google Scholar : PubMed/NCBI
|
50.
|
Galie M, Konstantinidou G, Peroni D, et
al: Mesenchymal stem cells share molecular signature with
mesenchymal tumor cells and favor early tumor growth in syngeneic
mice. Oncogene. 27:2542–2551. 2008. View Article : Google Scholar : PubMed/NCBI
|